VivoSeq
Other

Platelet Reactivity

0

Pipeline Programs↗

1

Active Trials↗

1

Companies Involved↗

Platelet Reactivity is an early-stage landscape with 0 programs across 1 company. The most active players are Eli Lilly.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

80/100

Attrition Rate

14/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Eli Lilly logo

Eli Lilly

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

28

clinical trials

Completed16 · 57%
Unknown status7 · 25%
Terminated3 · 11%
Not yet recruiting1 · 4%
Withdrawn1 · 4%

Clinical Trials

Trial Activity

28 trials

Modulation of Gut MicroFLORA With Rifaximin to Reduce High Platelet Reactivity in Post-ACS Patients on Ticagrelor
Not yet recruiting·CCollegium Medicum w Bydgoszczy·Phase 4·NCT07203846·50 enrolled
Impact of Extra Virgin Olive Oil Oleocanthal Content on Platelet Reactivity
Completed·UUniversity of California, Davis·N/A·NCT02902913·9 enrolled
Impact of Evolocumab on the Effects of Clopidogrel in Patients With High On-Treatment Platelet Reactivity
Completed·UUniversity of Florida·Phase 4·NCT03096288·259 enrolled
Platelet Reactivity After TAVI: A Multicenter Pilot Study
Completed·HHospital de Meixoeiro·Phase 4·NCT02224066·65 enrolled
Study of Policosanol to Improve Platelet Reactivity After Percutaneous Coronary Stent Implantation (PCI)
Completed·SShenyang Northern Hospital·Phase 4·NCT01371058·350 enrolled
Prasugrel Versus Clopidogrel to TREAT High Platelet Reactivity
Completed·UUniversity of Pecs·Phase 4·NCT01493999·147 enrolled
Platelet Reactivity in Stent Thrombosis Patients
Completed·SSt. Antonius Hospital·Phase 4·NCT01012544·187 enrolled
Therapy With High Clopidogrel Dose or Prasugrel Standard Dose Reduces the Platelet Reactivity in Patients With Genotype Variation RESET GENE Trial
Completed·—·Phase 3·NCT01465828·30 enrolled
Evaluation of Myocardial Reperfusion After Primary PCI in Patients With High Platelet Reactivity Treated by Cangrelor or Not
Completed·UUniversity Hospital, Caen·Phase 4·NCT04927949·128 enrolled
Platelet REACtivity According to TICagrelor Dose After Transcatheter AorticValve Implantation
Completed·—·Phase 4·NCT04331145·40 enrolled
A Study of the Effect of Epinephrine on Platelet Reactivity in Subjects Treated With Ticagrelor
Completed·—·Phase 1·NCT03441412·10 enrolled
Downstream Molecular Signals of P2Y12 Receptors in Hyporeactive Patients Under Clopidogrel Treatment A Possible Mechanism of HOTPR(High On-Treatment Platelet Reactivity)
Completed·TTaipei City Hospital·N/A·NCT03190005·35 enrolled
Effect of Low Dose of Colchicine on Platelet Reactivity
Completed·UUniversity of Sao Paulo·N/A·NCT05956145·80 enrolled
High On-treatment Platelet Reactivity Identified by Multiple Platelet Function Assay
Completed·WWuhan Asia Heart Hospital·N/A·NCT02699008·477 enrolled
Effect of Aspirin on Abacavir-induced Platelet Reactivity in HIV-infected Patients
Completed·AAzienda Ospedaliera di Perugia·Phase 2·NCT03316534·40 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)